Lipocalin-2 protects the brain during inflammatory conditions

Area of Science:

• Neuroscience
• Immunology
• Molecular Biology

Background:

• Sepsis can cause central nervous system (CNS) inflammation, leading to lasting cognitive and behavioral changes.
• Lipopolysaccharide (LPS) administration triggers a significant increase in Lipocalin-2 (LCN2) within the CNS.

Purpose of the Study:

• To investigate the protective or detrimental role of LCN2 in the CNS during systemic inflammation.
• To understand the impact of LCN2 deficiency on neuroinflammation and behavioral outcomes following LPS challenge.

Main Methods:

• Proteomic profiling to identify elevated CNS proteins after LPS administration.
• Comparative analysis of Lcn2 knockout (Lcn2-/-) and wild-type (WT) mice challenged with peripheral LPS.
• RNA sequencing (RNAseq) to analyze global transcriptional changes and identify LCN2-dependent pathways.

Main Results:

• Lcn2-/- mice exhibited exacerbated pro-inflammatory cytokine levels and worsened behavioral phenotypes compared to WT mice after LPS challenge.
• RNAseq revealed unique transcriptional profiles in Lcn2-/- mice, with elevated pro-inflammatory molecules.
• Identified LCN2-dependent pathways including cytokine/chemokine signaling, NOD-like receptor signaling, and JAK-STAT signaling.

Conclusions:

• LCN2 acts as a significant protective factor in the CNS against systemic inflammation.
• LCN2 may serve as a therapeutic target for mitigating sepsis-related CNS complications.